You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epidermolysis Bullosa Dystrophica

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional Trial in Paris (CACIPLIQ20, Placebo)

Not yet recruiting
  • Epidermolysis Bullosa Dystrophica
  • Epidermolysis Bullosa, Junctional
  • CACIPLIQ20
  • Placebo
  • Paris, France
    Hopital Necker - enfants malades
Aug 17, 2023

Artificial Intelligence Patient App for RDEB SCCs

Recruiting
  • Epidermolysis Bullosa Dystrophica
  • online survey
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
May 3, 2023

Recessive Dystrophic Epidermolysis Bullosa Trial (Spincare matrix)

Not yet recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • Spincare matrix
  • (no location specified)
Jul 12, 2023

Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)

Recruiting
  • Epidermolysis Bullosa Dystrophica
  • Squamous Cell Carcinoma
  • Rigosertib Oral Capsules / Rigosertib Intravenous
  • Salzburg, Austria
    EB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022

Growth Hormone in EB

Not yet recruiting
  • Epidermolysis Bullosa Dystrophica
  • growth hormone level and insulin like growth factor 1
  • (no location specified)
May 24, 2022

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

Dystrophic Epidermolysis Bullosa Trial (AGLE 102)

Not yet recruiting
  • Dystrophic Epidermolysis Bullosa
  • AGLE 102
  • (no location specified)
Apr 7, 2022

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica Trial in Worldwide (INM-755

Recruiting
  • Epidermolysis Bullosa Simplex
  • +3 more
  • INM-755 (cannabinol) cream
  • Vehicle Cream
  • Salzburg, Austria
  • +6 more
Mar 30, 2022

Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, New York (PTR-01)

Completed
  • Recessive Dystrophic Epidermolysis Bullosa
  • Redwood City, California
  • +1 more
Nov 17, 2022

Dystrophic Epidermolysis Bullosa Trial in Stanford (Topical beremagene geperpavec)

Completed
Has Results
  • Dystrophic Epidermolysis Bullosa
  • Topical beremagene geperpavec
  • Placebo gel
  • Stanford, California
    Stanford University
Jan 30, 2023

Recessive Dystrophic Epidermolysis Bullosa Trial in United States (FCX-007 (dabocemagene autoficel; see below for FCX-007

Active, not recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • FCX-007 (dabocemagene autoficel; see below for FCX-007 description)
  • Stanford, California
  • +4 more
Aug 10, 2022

Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa Trial in United States (RGN-137, Placebo)

Terminated
  • Junctional Epidermolysis Bullosa
  • Dystrophic Epidermolysis Bullosa
  • Evanston, Illinois
  • +4 more
Aug 18, 2022

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, Worcester (EB-101)

Active, not recruiting
  • Epidermolysis Bullosa
  • Recessive Dystrophic Epidermolysis Bullosa
  • EB-101
  • Redwood City, California
  • +1 more
Apr 5, 2022

Computational Drug Repurposing for All EBS Cases

Recruiting
  • Epidermolysis Bullosa
  • +5 more
  • Experimental Group
  • Palo Alto, California
    Pediatric Dermatology Clinic at Stanford Children's Hospital
Jan 11, 2022

Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa Trial in

Completed
  • Dystrophic Epidermolysis Bullosa
  • +2 more
  • Topical Beremagene Geperpavec
  • Placebo
  • Rancho Santa Margarita, California
  • +2 more
Aug 1, 2022

Dystrophic Epidermolysis Bullosa Trial (ALLO-ASC-SHEET, Vehicle Control)

Not yet recruiting
  • Dystrophic Epidermolysis Bullosa
  • ALLO-ASC-SHEET
  • Vehicle Control
  • (no location specified)
Feb 15, 2022

Epidermolysis Bullosa Dystrophica, Recessive Trial in Stanford, Aurora (FCX-007)

Active, not recruiting
Has Results
  • Epidermolysis Bullosa Dystrophica, Recessive
  • FCX-007
  • Stanford, California
  • +1 more
Sep 30, 2021

Recessive Dystrophic Epidermolysis Bullosa Trial in Worldwide (allo-APZ2-EB)

Completed
  • Recessive Dystrophic Epidermolysis Bullosa
  • allo-APZ2-EB
  • Minneapolis, Minnesota
  • +5 more
Oct 6, 2022

Explore the Role of Gut Flora in Epidermolysis Bullosa

Recruiting
  • Epidermolysis Bullosa
  • +2 more
  • No intervention
  • Ventura, California
    ProgenaBiome
Sep 2, 2021

The State of Sexual Development in Inherited Epidermolysis

Active, not recruiting
  • Dermatologic Disease
  • +7 more
  • Biochemical study of hormone levels
  • +3 more
  • Moscow, Russian Federation
    National Medical Research Center for Children's Health
Aug 26, 2021

Epidermolysis Bullosa Dystrophica, Recessive Trial in Paris (COL7A1-SIN retroviral vector engineered autologous

Active, not recruiting
  • Epidermolysis Bullosa Dystrophica, Recessive
  • COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin
  • Paris, France
    Institut Imagine Necker Hospital
Oct 18, 2021

Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Withdrawn
  • Dystrophic Epidermolysis Bullosa
  • DEB - Dystrophic Epidermolysis Bullosa
    • Redwood City, California
      Stanford University
    Sep 10, 2021

    Recessive Dystrophic Epidermolysis Bullosa Trial in Salzburg (Genetically corrected cultured epidermal autograft (ATMP))

    Terminated
    • Recessive Dystrophic Epidermolysis Bullosa
    • Genetically corrected cultured epidermal autograft (ATMP)
    • Salzburg, Austria
      EB House Austria, Department of Dermatology, Paracelsus Medical
    Feb 15, 2022

    Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, Aurora (PTR-01)

    Completed
    • Recessive Dystrophic Epidermolysis Bullosa
    • Redwood City, California
    • +1 more
    Sep 14, 2021

    Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)

    Recruiting
    • Recessive Dystrophic Epidermolysis Bullosa
    • Rigosertib Sodium
    • Quality-of-Life Assessment
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Aug 31, 2021